Treatments for Squamous Cell Cancer
Squamous cell cancer (SCC) development and recent preclinical and clinical advances for the effective prevention and treatment of the disease are covered in this book. Experts in the field describe here the cellular and molecular events in SCC development, recurrence, and metastasis, and provide an...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_97412 | ||
| 005 | 20230220 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230220s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-4757-2 | ||
| 020 | |a 9783036547589 | ||
| 020 | |a 9783036547572 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-4757-2 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MJCL |2 bicssc | |
| 100 | 1 | |a Darido, Charbel |4 edt | |
| 700 | 1 | |a Darido, Charbel |4 oth | |
| 245 | 1 | 0 | |a Treatments for Squamous Cell Cancer |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (168 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Squamous cell cancer (SCC) development and recent preclinical and clinical advances for the effective prevention and treatment of the disease are covered in this book. Experts in the field describe here the cellular and molecular events in SCC development, recurrence, and metastasis, and provide an updated snapshot on our understanding of the heterogeneity of SCC pathogenesis with novel opportunities in precision therapeutics to achieve better clinical outcomes. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Oncology |2 bicssc | |
| 653 | |a n/a | ||
| 653 | |a oral cancer | ||
| 653 | |a tobacco | ||
| 653 | |a alcohol | ||
| 653 | |a human papilloma virus | ||
| 653 | |a targeted sequencing | ||
| 653 | |a DNA copy number | ||
| 653 | |a TP53 | ||
| 653 | |a CDKN2A | ||
| 653 | |a EGFR | ||
| 653 | |a PIK3CA | ||
| 653 | |a anal cancer | ||
| 653 | |a radiation therapy | ||
| 653 | |a chemoradiation | ||
| 653 | |a de-escalation of therapy | ||
| 653 | |a pain | ||
| 653 | |a cathepsin S | ||
| 653 | |a protease-activated receptor-2 | ||
| 653 | |a PAR2 | ||
| 653 | |a cancer pain | ||
| 653 | |a oral squamous cell carcinoma | ||
| 653 | |a differentiation | ||
| 653 | |a terminal differentiation | ||
| 653 | |a oral epithelium | ||
| 653 | |a epithelial integrity | ||
| 653 | |a epithelial transformation | ||
| 653 | |a genetic alterations | ||
| 653 | |a therapy response biomarkers | ||
| 653 | |a cutaneous squamous cell carcinoma | ||
| 653 | |a immunotherapy | ||
| 653 | |a anti-PD1 | ||
| 653 | |a biomarkers | ||
| 653 | |a predictive medicine | ||
| 653 | |a personalized medicine | ||
| 653 | |a cancer | ||
| 653 | |a immune system | ||
| 653 | |a HNSCC | ||
| 653 | |a farnesyl transferase | ||
| 653 | |a tipifarnib | ||
| 653 | |a combination regimen | ||
| 653 | |a oropharynx | ||
| 653 | |a neoplasm | ||
| 653 | |a squamous cell carcinoma | ||
| 653 | |a human papillomavirus | ||
| 653 | |a therapeutic management | ||
| 653 | |a treatment selection | ||
| 653 | |a CSCC | ||
| 653 | |a treatment | ||
| 653 | |a advances | ||
| 653 | |a biology | ||
| 653 | |a immunocompromised | ||
| 653 | |a immune checkpoint inhibition | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/5974 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/97412 |7 0 |z DOAB: description of the publication |